Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco d'Amore

Showing results (31-40 of 119) with videos related to

Pageof 12
Sort By:
Indian Journal of Cancer|October 17, 2007
Clinical implication of genome-wide profiling in diffuse large B-cell lymphoma and other subtypes of B-cell lymphomaJaveed Iqbal, Shantaram Joshi, Kavita N Patel, et al.
Plos One|May 23, 2020
Glycolytic biomarkers predict transformation in patients with follicular lymphomaIda Monrad, Charlotte Madsen, Kristina Lystlund Lauridsen, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 5, 2014
Digital pathology for the validation of tissue microarrays in peripheral T-cell lymphomasMartin B Pedersen, Rikke Riber-Hansen, Patricia S Nielsen, et al.
Diagnostics (Basel, Switzerland)|July 12, 2025
Towards Precision Medicine in Sinonasal Tumors: Low-Dimensional Radiomic Signature Extraction from MRIRiccardo Biondi, Giacomo Gravante, Daniel Remondini, et al.
Acta Dermato-Venereologica|March 13, 2025
Systemic Targeted Therapies in Patients with Relapsed/Refractory Advanced Stage Cutaneous T-cell Lymphoma: A Real-world Single-centre Case SeriesSigne Hedebo, Martin B Pedersen, Lise M Lindahl, et al.
Scientific Reports|August 18, 2025
Lymph node transcriptomic profiles suggest susceptibility to bleomycin-induced pulmonary toxicity in classic hodgkin lymphomaMaja Dam Andersen, Marie Hairing Enemark, Kristina Lystlund Lauridsen, et al.
Histopathology|March 6, 2014
High intratumoral macrophage content is an adverse prognostic feature in anaplastic large cell lymphomaMartin B Pedersen, Allan V Danielsen, Stephen J Hamilton-Dutoit, et al.
British Journal of Haematology|July 16, 2010
Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphomaFrancesco d'Amore, John Radford, Thomas Relander, et al.
European Journal of Haematology|May 13, 2015
Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcomeMaja D Andersen, Peter Kamper, Patricia S Nielsen, et al.
Blood|April 21, 2011
Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphomaPeter Kamper, Maja Ludvigsen, Knud Bendix, et al.
Pageof 12

Showing results (31-40 of 119) with videos related to

Sort By:
Pageof 12
Indian Journal of Cancer|October 17, 2007
Clinical implication of genome-wide profiling in diffuse large B-cell lymphoma and other subtypes of B-cell lymphomaJaveed Iqbal, Shantaram Joshi, Kavita N Patel, et al.
Plos One|May 23, 2020
Glycolytic biomarkers predict transformation in patients with follicular lymphomaIda Monrad, Charlotte Madsen, Kristina Lystlund Lauridsen, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 5, 2014
Digital pathology for the validation of tissue microarrays in peripheral T-cell lymphomasMartin B Pedersen, Rikke Riber-Hansen, Patricia S Nielsen, et al.
Diagnostics (Basel, Switzerland)|July 12, 2025
Towards Precision Medicine in Sinonasal Tumors: Low-Dimensional Radiomic Signature Extraction from MRIRiccardo Biondi, Giacomo Gravante, Daniel Remondini, et al.
Acta Dermato-Venereologica|March 13, 2025
Systemic Targeted Therapies in Patients with Relapsed/Refractory Advanced Stage Cutaneous T-cell Lymphoma: A Real-world Single-centre Case SeriesSigne Hedebo, Martin B Pedersen, Lise M Lindahl, et al.
Scientific Reports|August 18, 2025
Lymph node transcriptomic profiles suggest susceptibility to bleomycin-induced pulmonary toxicity in classic hodgkin lymphomaMaja Dam Andersen, Marie Hairing Enemark, Kristina Lystlund Lauridsen, et al.
Histopathology|March 6, 2014
High intratumoral macrophage content is an adverse prognostic feature in anaplastic large cell lymphomaMartin B Pedersen, Allan V Danielsen, Stephen J Hamilton-Dutoit, et al.
British Journal of Haematology|July 16, 2010
Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphomaFrancesco d'Amore, John Radford, Thomas Relander, et al.
European Journal of Haematology|May 13, 2015
Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcomeMaja D Andersen, Peter Kamper, Patricia S Nielsen, et al.
Blood|April 21, 2011
Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphomaPeter Kamper, Maja Ludvigsen, Knud Bendix, et al.
Pageof 12